Trial Profile
A retrospective study to evaluate the effect of Ocriplasmin in patients with macular hole surgery
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 May 2019
Price :
$35
*
At a glance
- Drugs Ocriplasmin (Primary)
- Indications Retinal perforations
- Focus Therapeutic Use
- 19 May 2017 New trial record